ArticleCancer research2013
OX40 is a potent immune-stimulating target in late-stage cancer patients.
Brendan D Curti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
257 papers cite itlatest 60 shown
this paperpooled ittrialcites it